Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora’s leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country’s expanding patient base.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- Aurora Cannabis Schedules Q3 2025 Investor Conference Call
- Rising High: Exclusive talk with pharmaceutical development company MIRA
- DEA judge postpones cannabis rescheduling hearings, Marijuana Moment reports
- Rising High: Innovative Industrial reports PharmaCann default
- Rising High: Exclusive talk with biopharma company HMNC Brain Health